The gastrointestinal tract is a centre of absorption and secretion, with the capacity to sustain microbial and viral pathogen assault as well as regenerate following damage by infections or radiation 1,2 . The complex morpho logy of the intestine includes the crypts of Lieberkuhn as well as the villus and surface enterocytes, and has been well described [3] [4] [5] . The use of in vitro intestinal models, such as T84 or Caco2 cells, has led to breakthroughs in understanding of functional intestinal physiology and cancer biology, but has also shown disparate results from rodent models 6 . The three segments of the small intestine (duodenum, jejunum and ileum) and the proximal and distal colon have been shown to have segment specificity in transport, protein expression and pathogeninduced disease [7] [8] [9] . Discoveries have also come from the use of ex vivo, selfassembling 'miniguts' , termed organoids (derived from iPS (induced pluripotent stem) cells) 10 , enteroids and colonoids (derived from adult stem cells from the small intestine and colon, respectively) 11 . Although these miniguts have been studied in detail for intestinal development and stem cell lineage, fewer stud ies have investigated their use as functional physiology and pathophysiology models.
health and disease, and the effects of enteric pathogens on the host intestinal epithelia, including pathogen colon ization [14] [15] [16] . Notably, these cell lines are immortal ized cancerderived cells, and might not accurately rep resent the normal, healthy human intestine. Although these lines have been used to model the human intestine owing to their ability to replicate intestinal permeabil ity and membrane transport, studies have shown that subclones of these cell lines, in particular Caco2, have disparate protein expression and mislocalization from laboratory to laboratory, and also show differing pro tein expression compared to the human intestine 17, 18 . Additionally, these commonly used in vitro cell lines lack intestinal segment specifi city and also consist of a single cell type, a misleading representation of the complex multicellular identity of the intestine. Thus, some studies in both intestinal physiology and patho physiology have been misleading. A prime example is passive and carriermediated drug absorption in the intestine 18, 19 . Comparisons between human intestinal samples and Caco2 cells showed that passive drug absorption was similar, resulting in the use of Caco2 cells as a model for drug absorption in the intestine dur ing drug discovery 14, 20 . However, the rate of active drug absorption in Caco2 cells does not necessarily correlate to the rate of active drug absorption in humans. In some cases, drugs are poorly or not absorbed in Caco2 cells but are absorbed in the human intestine 18, 19 . These find ings might be explained in part by the reduced expres sion of several transporters in Caco2 cells compared with the human intestine 18 . Furthermore, Caco2 cells begin to differ in functional and transport character istics as their passage number increases, or as they age 21 . Disparate findings between the immortalized cell lines and rodent intestine have added to the con fusion. For example, the functional role of cyclic GMP dependent protein kinase II (cGKII) in ion transport was contradictory between T84 cells (no cGKII involve ment) 22 and mouse intestine (cGKII is involved in fluid homeo stasis) 23 . Another marked difference has been reported for the bile salt transporter ASBT between Caco2 cells and mouse intestine 24 . Although not fully understood, ASBT might be regulated by differing mechanisms or differing Ptype ATPases in Caco2 cells and mouse intestine. These examples highlight the need for a physiological model that is more representative of the normal human intestine.
Most of the intestinal in vitro cell lines represent enterocytes, and therefore do not produce the thick outer mucus layer (primarily composed of MUC2) that serves as the first point of contact between enteric patho gens and the host intestine 25 . As studies have shown, the outer mucus layer provides a defence mechanism as well as a nutrient source for both pathogens and gut micro biota 9, 26, 27 . These findings emphasize that the commonly used in vitro lines have limited value for host-pathogen studies. Thus, a better system to model the human intestine is needed.
Human ex vivo models Organoids The two cell sources used for the formation of organoids are human iPS cells or, less often, embryonic stem cells. These cell sources are differentiated into 3D human intestinal organoids (HIOs) 10, 28 . HIOs are useful for understanding the developmental biology of the intes tine as they initially represent a fetallike intestine that does not mimic intestinal segment specificity 29 . However, HIOs have been shown to form large pieces of intestine with villilike structures when transplanted under the kidney capsule of a mouse 30 . This HIOderived intes tine can be removed and used for crypt isolation and enteroid formation.
The conversion of iPS cells into in vitro HIOs was pioneered by Wells and colleagues. Their work elegantly describes how initial conversion into HIOs involves sequential manipulation of signalling pathways that mimic in vivo intestinal development 10, 31 . Activin A, a mimic of Nodal and member of the TGFβ family, initi ates expression of the transcription factors Sox17 and HNF3beta (FOXA2), leading to posterior endoderm
Key points
• Human 'mini-guts' generated from crypt-based or induced pluripotent stem (iPS) cells functionally recapitulate normal intestinal transport physiology and model pathophysiologic changes following interactions with enteric pathogens • iPS-cell-derived intestinal organoids can be used to model intestinal development and engrafted in vivo to differentiate the epithelium along a crypt-villus axis supported by subepithelial and smooth muscle layers • 3D enteroids and colonoids derived from intestinal stem cells can be used to measure ion, nutrient and water absorption or secretion as part of normal intestinal transport function • Both human intestinal organoids and enteroids or colonoids can be used as models to study enteric bacterial and viral pathogenesis • Enteroids and colonoids can be grown on 2D permeable supports to enable apical access to study host-pathogen interactions as well as drug absorption and/or metabolism • Stem cell or iPS-cell-derived gastrointestinal organoids from the stomach, pancreas and liver are also being developed as models to study development, infection and regenerative medicine 30 . However, as in enteroids, the HIOs lack a vascular plexus, M cells, Peyer's patches, mesenteric lymph nodes and enteric nerves.
Although HIOs are polarized (with a luminally facing brush border) and can perform some transport functions, such as dipeptide absorption, they are fetal in nature and do not reproduce segment specificity by expressing proteins specific for the duodenum, jejunum, ileum, or colon 28 . Rather, HIOs form a mixed popu lation of proximal intestinal cells (expressing GATA4 and GATA6) and distal intestinal cells (expressing GATA6, but not GATA4). However, attempts are ongoing to use HIOs to produce mature intestine with segment specificity. The most developed method prov ides HIOs with a highly vascular environment by implantation beneath the kidney capsule of mice or enclosure in the omentum 30 . This approach has led to a marked increase in the size of the implanted HIOs, with distinct crypt and mature villus compartments, as well as conversion from fetal to more mature adultlike small intestinal character istics. However, this method does not cause segmental differentiation of the HIOs into specific parts of the small intestine (duodenum, jejunum and ileum) 30 . Other changes include develop ment of brush border enzymes involved in digestion, production of defensins and expression of the stem cell marker OLFM4 in the crypts 29 . After removal from beneath the kidney capsule, the mature HIOs express the intestinal cell lineages seen in mature small intes tine. The enterocytes have a mature brush border and tight junctions and show increased expression of brush border proteins (such as sucrase isomaltase, dipeptidyl peptidase IV, trehalase, maltase, and lactase) 30 . Other cell lineages distribute along the crypt-villus axis similarly to the normal intestine, including the crypt residing Paneth cells and the proliferative stem cells at the crypt base. Given that the implanted HIOs grow exponentially in size, they have been excised and used to generate enteroids, which can be propagated and differentiated as ex vivo cultures 32 . The advantages of using HIOs over enteroids and colonoids include the ability to study various stages of development and lumen formation 31, 32 , the inclusion of myofibroblasts to create a more complex stem cell niche than that which exists in enteroids and colonoids and the additional Wnt source from the mesenchyme (which is also probably more similar to normal intesti nal homeo stasis). The disadvantages include the length of time and effort needed to create a single HIO line (~35 days to 3 months), the fetal nature of the epithelium and the lack of segment specificity
.
Enteroids and colonoids
Human enteroids (small intestine) and colonoids (large intestine) are ex vivo primary intestinal cultures derived from the crypts of paediatric or adult intestine 11 . The intestinal tissue source is generally biopsy samples obtained endoscopically or from surgical resections. Although the nomenclature of these cultures has been inconsistent, this Review refers to the nomenclature of tissuederived miniintestines as enteroids or colonoids, as described by the NIH National Institute of Diabetes and Digestive and Kidney Diseases Intestinal Stem Cell Consortium 33 . The successful development and propa gation of human enteroids and colonoids is dependent on numerous growth factors that mimic those secreted by the mesenchyme and create an ideal intestinal stem cell niche for the LGR5 + intestinal stem cells 34, 35 . These growth factors have been described extensively in pre vious reviews [36] [37] [38] [39] . The most critical growth factor is WNT3A. Although Paneth cells are required for the intestinal stem cell niche and are thought to produce WNT3A 35 , it is in too low abundance to support the stem cell niche needed to continuously grow human enter oids and can be compensated by exogenous WNT3A in the media.
Using the growth factors first described by Sato et al. 11, 40 , enteroids and/or colonoids can be produced from each segment of the small intestine (duodenum, jejunum and ileum), colon (proximal, transverse, distal), and rectosigmoid. These cultures grown ex vivo have been maintained in various laboratories for >2 years with no detectable changes in chromosomal number or other cancerous characteristics of wildtype cultures 41 . As documented for the small intestinal enteroids, they maintain protein expression characteristic of the specific intestinal segment (including specific tran scription factors that define the segments) or suppress protein expression normally not found in that specific segment 8 . Initial growth of enteroids is polarized (as with the normal intestine), forming spheroids with the apical surface facing inwards and apical microvilli and baso lateral Na + K + ATPase, Cadherin1 (Ecadherin), and Catenin beta1 (betacatenin) expression. However, these enteroids express a protein profile that is more similar to that expressed by the crypt 8 . Thus, they are considered 'not differentiated' and remain in a highly proliferative state in culture (FIG. 1a) . Withdrawal of WNT3A induces a loss of proliferation (FIG. 1a) and a distinct pattern of differentiation in all cells 42 ; two, structural changes such as a luxuriant glycocalyx and the develop ment of dense, long microvilli that are uniform in length owing to their coordinated connection and growth by Cadherinrelated family member 2 (protocadherin24) bridges 9 ; third, enzyme expression related to the brush border of the villus and not cryptresiding cells, such as alkaline phosphatase, sucrase isomaltase and lactase; fourth, dis appearance of the evidence of proliferation at 3-4 days after WNT3A removal, seen with the negative staining of Ki67 and EdU 8 ; fifth, markedly increased amounts of MUC2 production, with a visible inner MUC2positive mucus layer on 2D colonoid cultures that are up to 50 μM thick 9 (FIG. 1b) . The differentiation state described in BOX 2 is representative of the increased protein expression of the surface villus cells.
Box 2 | Differentiation of enteroids: proteins

Brush border
The advantages of using enteroids and/or colonoids include segment specificity, the ability to study genetic diseases (as the adult stem cells from these cultures retain the identity of the donor), CRISPR/Cas9 gene editing 41, 44, 45 , potential uses for regenerating damaged intestinal tissue 46 , and potential for individualized drug screening and therapy 47 , a major boon for precision med icine. The disadvantages include an inability to study intestinal development from the embryonic stage and the lack of a mesenchyme 34 , immune cells and enteric nerves, thereby creating a need to reimplement all lack ing intestinal components to mimic a complete human intestine
Intestinal transport physiology Current understanding of intestinal physiology has been derived from an amalgam of in vivo studies performed in rodents and human volunteers [48] [49] [50] , and ex vivo measure ments performed with excised tissues from either animals and humans or cancerderived cell lines [51] [52] [53] [54] [55] [56] [57] . The pitfalls of each model have been previously discussed, but the real lessons from these endeavours is that to answer a par ticular question, the model must be neither too complex nor too reductionist. Although ion transport is acknow ledged to be influenced by multiple factors outside of epi thelial cells, studies within a whole organism are often complicated and are not tractable, and experiments in overexpressed systems or immortal cell lines lack the full complement of normal cellular function and response. Enteroids and colonoids are a tractable model that are more representative of the human intestine than in vitro cell lines, and more easily handled than whole organ ism studies. These tissuederived miniintestines enable basic observations to be made and then be built upon as nonepithelial cell types are integrated into culture.
Functional ion transport physiology and pathophysio logy has been demonstrated in 3D enteroids 58, 59 via assays for stimulated anion and/or fluid secretion and basal neutral sodium chloride (NaCl) absorption 8 . Stimulated luminal dilatation in enteroids is a powerful applica tion that can be used to screen for secretory defects and potential therapies. The forskolininduced swelling assay, in which increased cAMP triggers cystic fibrosis trans membrane conductance regulator (CFTR)mediated anion and fluid secretion into the closed lumen of the enteroid, was the first secretion study in human enteroids 47 (FIG. 2a) . Using the forskolininduced swelling assay, CFTR correctors and potentiators could be assessed for efficacy in rectal colonoids derived from patients with cystic fibro sis to identify a combination of drugs that restore normal CFTR activity to otherwise nonresponding enteroids. Swelling assays can also be performed with other secreta gogues or ion transport inhibitors, such as carbachol and the enterotoxin domain of rotaviral protein NSP4 (REF. 60 ). The extent to which dilatation is diminished in the pres ence of specific ion transporter inhib itors indicates the relative contribution of a transporter to overall ion homeo stasis 8 and has resulted in a new model for active basal transport for both the undifferentiated (crypt and transit amplifying regions) and differentiated (mature surface enterocytes) enteroids (FIG. 2b) .
The other major transport change in diarrhoeal dis eases is decreased neutral NaCl absorption, which is assessed by measuring the rate of Na + /H + exchanger 3 (NHE3) activity using a pHsensitive ratiometric fluoro phore and multiphoton microscopy 8, 61 (FIG. 2c) . The assay consists of NH 4 Cl prepulse, Na + free incubation to induce acid loading and reintroduction of Na + to induce pH recovery to baseline conditions. Duodenal enteroids exhibited the expected response to NHE3 inhibitors, enterotoxins and second messengers in this transport assay 8 .
Host-pathogen interactions
Although the number and severity of enteric pathogen outbreaks is substantially decreasing worldwide (from 800,000 to 250,000 deaths per year) owing to the use of oral rehydration solution, new vaccine developments and improved sanitation, many bacteria and viruses continue to cause lifethreatening epidemics in develop ing and developed countries 62, 63 . Even though the per patient frequency of diarrhoea is decreasing, because of the increasing population in developing countries, the number of diarrhoea cases per year is increasing or stay ing near constant. This problem is evidenced by deaths from outbreaks of Vibrio cholerae in Haiti 64 (with ~10,000 deaths), Shigatoxinproducing Escherichia coli in Europe and the USA [65] [66] [67] , and the consider able increase in the numbers of Clostridium difficile cases in hospitals [68] [69] [70] . No specific FDAapproved thera pies exist against these and other enteric pathogens. Increased use of antibiotics often leads to greater harm rather than a cure by select ing for antibioticresistant 'superbugs' and/or highly toxigenic strains, as well as causing bacteria to increase the release of luminal virulence factors [71] [72] [73] [74] . As discussed, a major hurdle that has contributed to the lack of specific treatments for many entericpathogencaused illnesses is the absence of a physiologically relevant preclinical intestinal model of pathogeninduced human disease. Although numerous animal models have been used to study human enteric pathogens, they have not prov ided a breakthrough in understanding the complex ity of intestinal damage nor led to the development of successful therapeutic interventions 75 . Both HIOs and enteroid or colonoid cultures are quickly gaining a role as an indispensable model for host-pathogen inter actions. The interactions of enteric pathogens -such as C. difficile, Salmonella enterica, rotavirus and entero haemorrhagic E. coli (EHEC) -with the human intes tinal epithelia have already been demonstrated using these models (TABLE 1) . Use of these models enables, for the first time, elucidation of the varying roles that the complex ecosystem of t intestinal epithelial cell types have in pathogen colonization, replication, host damage and clearance of infection.
For example, the role of mucus 76 and paracellular dysfunction 77 in C. difficile infection (CDI) has been studied using HIOs microinjected with C. difficile. Although C. difficile alone was sufficient to reduce the production of MUC2 (a major gelforming mucin), it was not capable of altering the mucus oligosaccharide composition 76 . Additionally, using HIOs to improve understanding of the mechanisms contributing to diar rhoea induced by C. difficile found substantial transcrip tional down regulation of the major sodium absorbing protein NHE3 (REF. 78 ). These data might explain the high sodium concentrations found in the stool of patients with CDI 78, 79 . However, C. difficile is primarily a colonic infection, which can lead to colitis. The above mentioned studies were all performed in HIOs, a dis advantage in that they are fetallike and do not model the adult colon. To avoid confounding results, future intestinal host-pathogen studies need to be modelled in the accurate intestinal segment.
HIOs seem to be a promising model to explore the interaction of S. enterica serovar Typhimurium with the human intestinal epithelium 80 . Salmonella microinjected into the lumen of HIOs was able to invade the epithe lial barrier and take up residence within Salmonella containing vacuoles, as well as change the transcriptional profile of the host, including altering the patterns of cytokine expression after exposure to bacteria.
Both human proximal small intestinal enteroids and HIOs have been shown to model human rotavirus infec tion 39, 60, 81, 82 . Rotavirus replicates and produces infectious virions in enteroids and HIOs, with viral replication increasing over 96 h 60, 82 . Moreover, an increased degree Nature Reviews | Gastroenterology & Hepatology a pH-sensitive fluorophore to monitor pH changes when exposed to various buffers. In the example shown, incubation in NH 4 + buffer will lead to a basic pH and will be represented by the pH-dependent emission of a red fluorophore. Replacement of the buffer with a Na + -free buffer causes a sharp decrease to acidic pH and will be represented by emission of a green fluorophore. The pH is increased to basic levels by incubation in Na + buffer. The change in pH over time indicates NHE3 activity of the enteroids.
of infection (~50%) in differentiated human enteroids exposed to human rotavirus has been demonstrated compared to simian strains 60 . Differentiated enteroids are comprised of mature epithelial cells that normally reside in the upper region of small intestinal villi and have been shown to be the site where rotavirus infection occurs 8 . Additionally, rotavirus antigen was found in entero endocrine cells, suggesting the importance of serotonin production in rotavirusinduced diarrhoea and patho genesis 60 . Human enteroids provide the only model intes tinal system that will enable future studies on specific subsets of enteroendocrine cells and their importance during rotavirus infection. Rotavirus infection causes rapid dilation of the enteroid lumen as well as inhibition of NHE3, which might be an important contributor to rotavirusinduced diarrhoea (modelled in FIG. 3) 
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. Given that the pathophysiology of rotavirusinduced diarrhoea remains poorly understood, the technological advance ment of growing enteroids as monolayers, in addition to the already described 3D assays, enables mechan istic investigation and identification of the ion and water transporters affected by rotavirus infection.
The topographical nature of 3D Matrigel (Corning Life Sciences, USA)embedded intestinal cultures pre sents limitations for their use in studying epitheliumpathogen interactions. Enteroid size, number of cells per enteroid and luminal volumes can vary. Additionally, the enteroids have restricted luminal access, thus requiring microinjection of the pathogen into the lumen of each individual enteroid or organoid. We and others 9, 39, 83 are pioneering an innovative model of host-pathogen interactions using human enteroid or colonoid mono layers. This 2D model takes advantage of the stability of the 3D enteroids and colonoids to fragment the 3D cul tures and grow them as a monolayer on semipermeable supports, enabling apical exposure to pathogens. The differentiated monolayers expresses all major cell types present in the small intestine and colonic epithelium 83 and in 3D cultures, including enterocytes, colonocytes, enteroendocrine and mucinproducing goblet cells. The monolayers enable controlled access to both apical and basolateral surfaces to facilitate highly reproducible measurements of pathogen-epithelial interactions that are restricted in the 3D spherical cultures. This tract able 2D model enables ex vivo monitoring of the initial steps (several hours postinfection) in the interaction between Shigatoxinproducing EHEC and the human colonic epithelium, a feat not achieved in whole animal models 9 . Given that differentiated human colonoid mono layers produce a thick, impermeable mucus layer (FIG. 1b) , as described in in vivo human colon 84, 85 , they present a more physiologically relevant model for EHEC infection. Indeed, a novel finding showed that EHEC destroys the inner mucus layer, using the mucus as a highenergy sub strate for colonization and possibly as an initial anchor 9, 26 . The human colonoid monolayer presents a novel tool to study the interactions of the colonic mucus with enteric pathogens and the commensal flora, which do not have the ability to degrade mucus, and also enables valid ation of previously studied phenotypes of EHEC infec tion, such as occludin mislocalization and brush border degrad ation (FIG. 3) . Human enteroid and colonoid mono layers are undergoing validation as a physiologically rele vant model to identify the individual genetic differences in host-pathogen interactions, and assess and predict the changes in epithelial permeability and drug absorp tion and/or metabolism in normal physiology versus enteric infections.
Other gastrointestinal tract organoids
The success of small intestinal and colonic miniguts has led to the culturing of other organs along the digestive tract [86] [87] [88] [89] [90] [91] [92] [93] [94] . For example, similar to the intestine, relevant gastric models are lacking 90 . Most gastric in vitro cell lines are derived from gastric cancer 95 , and therefore do not represent normal gastric epithelium. Primary gastric cultures can be obtained but were unable to be expanded in vitro, possibly due to the lack of appropriate growth factors, resulting in shortlived cultures unsuitable for extensive physiological or pathophysiological studies 96 . However, preliminary studies with gastric organoids have found that they represent a novel pathophysio logical model for the study of host response to Helicobacter pylori infection 88 . Similarly to the intestinal cultures, gastric organoids can be generated from either iPS 90 or adult stem cells isolated from surgical sections of the gastric corpus 87 . iPS cells differentiated into endoderm are generated into the foregut with the addition of WNT3A, FGF, and Noggin
90
. These growth factors enable SOX2 expression but CDX2 repression, thus preventing hindgut forma tion. Addition of retinoic acid to the foregut spheroids causes an increase in PDX1 expression, resulting in high PDX1 and SOX2 expression and differentiation into the segmentspecific antrum. Addition of EGF causes further differentiation from immature antral spheroids to mature antral organoids that form glandular and pit like structures 90 . Interestingly, RNA sequencing showed that iPSderived gastric organoids maintain a similar transcriptional profile as human fetal stomach 90 . By con trast, gastric organoids derived from adult stem cells maintain their adult characteristics throughout culture and differentiation 87, 88 . Culture conditions do not affect histology or cause chromosomal aberrations, as normal or tumourderived sections continued as normal or tumourderived organoids, respectively 87 . Similar to the iPSderived gastric organoids, these cultures also require temporal addition or removal of various growth factors for both longterm maintenance and differentiation into either glandular or pit structures.
Regardless of origin, both types of gastric organoids respond to H. pylori infection. H. pylori is a common gas tric pathogen that can cause severe peptic ulcers 97 . Given that H. pylori resides in the gastric lumen, 3D organoids were microinjected with H. pylori to mimic infection. After a shortterm infection (2 h), the gastric organoid upregulates genes associated with pro inflammatory pathways, known host responses to H. pylori infec tion 87, 90 . Further studies have validated humanderived fundic gastric organoids (hFGOs) as a functional model of H. pylori infection in a study focusing on CagA (an important virulence factor for H. pylori), its receptor tyrosine kinase cMet and the cell surface adhesion mol ecule CD44. The proliferative response was blocked in hFGOs microinjected with a ΔcagA mutant strain or exposed to a cMet inhibitor before infection with wildtype H. pylori 98 . CD44, a coreceptor for cMet and putative gastric cancer stem cell marker 99 , was shown to have a role in the prolifer ative response to H. pylori infection. These initial studies highlight the physio logical importance of human gastric organoids over other gas tric models in understanding gastric development and pathogenicity of H. pylori.
In addition, hepatic organoids from human iPS cells and human adult bile duct cells have been successfully cultured and maintained in vitro 93, 94, 100 . However, the architectural complexity of the mature adult liver has limited these functional physiology and patho physiology assays. Although liver organoids can mimic the disease phenotype of the patient Another approach uses human iPS cells and manipulation of GATA6 levels to codifferentiate into parenchymal hepatocytes and stromal cells to form a more complex liver bud 92 . Both approaches enable the study of hepatic development from the embryonic state but the organoids remain fetal in nature when differentiated into liver buds. Hepatic organ oids from human adult bile duct cells retain the genetic signature of the donor 94 , opening up possibil ities of regener ative medicine and specific host-pathogen interaction. Although no studies have yet detailed patho physiology using hepatic organoids, the success of sev eral groups in generating stable and longterm hepatic cultures suggests these studies are not far behind.
Future challenges
The use of human gastrointestinal miniintestines (encompassing iPSderived or tissuederived enteroids and colonoids) has led to rapid advances in understand ing intestinal development, physiology and pathophysio logy. However, numerous challenges will need to be addressed. Both intestinaltissuederived and iPS derived miniintestines represent a reductionist model. Although more complex than in vitro intestinal and colonic cell lines, they do not fully represent the human digestive tract in vivo. For example, they lack vascula ture, an enteric nervous system and resident microbiota. The advancement of a 2D human organoid system might enable these components to be added individually, in a sandwichstyle model, but will also require a represent ative basal media. Adding microbiota will require an oxygen gradient, another component currently lacking from this model.
The intestinaltissuederived enteroids or colonoids have been shown to retain 'patient specificity' , even over multiple passages 44, 47 . This phenomenon has incredible potential for personalized, or precision, medicine, and future drug development studies. However, these hetero geneous populations present an interesting challenge for drug discovery assays. Whether iPSderived organoids will be able to compensate as a uniform intestinal model for future drug discovery remains to be discovered. Both the enteroid, colonoid and iPS organoid models require further characterization as to their specific advantages for drug discovery, drug development, and individual ized precision medicine. The advent of CRISPR/Cas9 as a genetic modification tool to correct mutations 44 prov ides an exciting future in precision gene therapy and intestinal transplantation.
Conclusions
The gastrointestinal organoids and enteroids and/or colonoids present a novel model that has led to discover ies in homeostatic intestinal physiology and interactions between enteric pathogens and host intestinal epithelia. Basal or stimulated ion secretion and absorption can be measured using both the 2D and 3D enteroid cultures. To minimize cellular injury, enteroids and colonoids can be directed to a 2D morphology with direct access to the apical surface. This approach enables direct hostpathogen studies at the earliest stages of infection in a functionally and physiologically relevant human model. Use of this model might lead to novel pathophysiological interactions, which will advance curative or preventive therapies for enteric infections.
